Navigation Links
Xanodyne Announces Renewed Focus on Pain Management Market
Date:5/10/2010

NEWPORT, Ky., May 10 /PRNewswire/ -- Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, today announced that it has tightly focused the strategic direction for the company on the pain management market.  The company plans to leverage its core expertise in the prescription pain category by developing a range of products that address both the acute and chronic pain prescription segments as well as the over-the-counter pain market.

Xanodyne has nearly a decade-long history as a pain management company with well known brands such as Darvocet-N® (propoxyphene napsylate and acetaminophen), Roxicodone® (oxycodone hydrochloride) and Oramorph® SR (morphine sulfate sustained release).  The most recent addition to its focused pain portfolio is Zipsor® (diclofenac potassium) Liquid Filled Capsules, a non-steroidal anti-inflammatory drug (NSAID), approved by FDA in June 2009 for the treatment of mild to moderate acute pain in adults.  Diclofenac, the active ingredient in Zipsor, is one of the most widely prescribed NSAIDs in the world.  

As a result of the new business strategy, Xanodyne has divested the global rights of its women's health asset, Lysteda™ (tranexamic acid) to Ferring Pharmaceuticals, a global bio-pharmaceutical company headquartered in Switzerland.  Details of the transaction have not been disclosed. Lysteda was approved following a Priority Review by FDA in November 2009 as a first-in-class non-hormonal, oral therapeutic agent indicated specifically for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.  

"We are very excited about the prospects for our strategic f
'/>"/>

SOURCE Xanodyne Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
2. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
3. Medco Announces Webcast for Annual Meeting of Shareholders
4. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Announces Election of New Officer
5. Hill-Rom Announces Third Quarter 2010 Dividend
6. Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
7. ADVENTRX Pharmaceuticals Announces Closing of Financing
8. China Pharma Holdings, Inc. Announces May Investor Conference Participation
9. LightLab Imaging Announces FDA Clearance of C7-XR(TM) Coronary OCT Products in the United States
10. Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit
11. Mylan Announces Proposed Senior Notes Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Del. , Aug. 28, 2014  Rigrodsky & Long, P.A.: ... of Lannett Company, Inc. (NYSE: LCI )? , ... September 10, 2013 and July 16, 2014, inclusive? , ... , Do you want to discuss your rights? ... Special Assistant United States Attorney, Timothy J. MacFall , announces ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that a ... catalogue: Germany Aesthetic Lasers and Energy ... http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html Germany Aesthetic Lasers ... Summary GlobalData,s new report, "Germany Aesthetic Lasers ... key market data on the Germany Aesthetic Lasers ...
(Date:8/28/2014)... 2014 Pharmatech initiated enrollment for its ... game-changing method for matching cancer patients to cancer ... target specific cancers, disease staging, and genetic mutations ... cancer, in the first place. The challenge that ... not be well known to the patient or ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2
... 2012 SERVE-HF, the largest study to investigate ... and outcomes of patients with stable heart failure, has enrolled ... Ltd., is the largest of its kind. This milestone brings ... to its target of approximately 1,250 participants. Principal ...
... N.J., May 18, 2012  Watson Pharmaceuticals, Inc. (NYSE: ... announced today that Paul Bisaro, Watson,s President and Chief ... the Company,s business at the Sanford C. Bernstein 28th ... at 4:00PM Eastern Time at the Waldorf-Astoria Hotel in ...
Cached Medicine Technology:Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant 2Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant 3Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference 2
(Date:8/28/2014)... August 29, 2014 Recently, iFitDress.com, the ... new selection of chic bridesmaid dresses . Included ... items. In addition, all of them are provided at ... , iFitDress.com insists on offering fast and reliable delivery ... what they order in a short time. As is ...
(Date:8/28/2014)... August 28, 2014 Blood's Thicker Than Water ... money and family ties in the heart of the city. ... – a story about how disrespect caused two families to ... many streets. , The Yayo Boyz and the M.O.B. Boyz ... speechless and local onlookers in a silent terror. "Guerrilla," AKA ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 Millennium ... use affecting users in the workplace. A recent ... Dependence (NCADD) states that drug abuse is costing ... who use or are addicted to drugs affect their ... activities carry over into the workplace, causing expensive problems ...
(Date:8/28/2014)... government plans its exit strategy from the war, now may ... providing health care to veterans, says a Perspective piece in ... simply go on doing more of the same is to ... cost and population structure pose in the longer run," said ... Clinical Practice, and David Auerbach, from the RAND Corporation, in ...
(Date:8/28/2014)... 2014 The Governor of Yucatán, Rolando ... at a press conference; this event is organized by ... of Economy through the National Microenterprise Financing Program ( ... to the 5th at the Convention Center Yucatan Siglo ... a great responsibility for Yucatan to host the 17th ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Raymond E. Blake Releases Blood's Thicker Than Water, Based on a True Story 2Health News:Drug Use Causes Problems in the Workplace 2Health News:A VA exit strategy 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3
... COSTA MESA, Calif., Jan. 21 Talk About ... of a $300,000 multi-year grant from the Newport Beach ... of this generous contribution, TACA will launch three new ... program, the addition of an in house advocate to ...
... Nu Skin Enterprises, Inc. (NYSE: NUS ) today ... financial results prior to the market opening on Friday, Feb. ... a conference call with the investment community later that same ... participants can expect to hear management review past results and ...
... uninsuredsteeply rising insurance premiumsemployers cutting healthcare benefits. , ... Diagnoses, and Dollars: Facing the Ever-Expanding Market for ... America,s healthcare industry to task and challenges readers ... Provocative, timely, and comprehensively researched, this book analyzes ...
... Alliance Tech ( http://alliancetech.com ), the leader ... that Carestream Health, Inc., used the company,s ... lead opportunities with attendees at the Radiological ... in Chicago in early December. (Logo: ...
... critical for physicians to understand potential risks when communicating with ... national insurer of physician and surgeon medical liability with 44,000 ... telemedicine liability risks. , ... Napa, ...
... Tenn., Jan. 21 Healthcare Management Systems,Inc.(R) (HMS) announced ... supply a full suite of financial solutions for the ... system will provide much needed,integration for the 26-bed hospital ... also include technology to get them closer to an ...
Cached Medicine News:Health News:Talk About Curing Autism Receives $300,000 Grant From Pacific Life Foundation to Provide Services for Families Affected by Autism in Orange County 2Health News:Alliance Tech's RFID Technology Enhances Carestream Health's Capability to Connect with Key Prospects at RSNA 2Health News:Alliance Tech's RFID Technology Enhances Carestream Health's Capability to Connect with Key Prospects at RSNA 3Health News:The Doctors Company Provides Tips for Physicians to Minimize Risk While Practicing Medicine by Phone or E-mail 2Health News:The Doctors Company Provides Tips for Physicians to Minimize Risk While Practicing Medicine by Phone or E-mail 3Health News:The Doctors Company Provides Tips for Physicians to Minimize Risk While Practicing Medicine by Phone or E-mail 4Health News:Yalobusha General Hospital Selects HMS to Provide Information Technology Infrastructure 2
Inquire...
300 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 250 and 300 L pipettes....
... Aerosol barrier tips eliminate false signals ... designed and tested, Promega Barrier Tips ... with amplified nucleic acids (PCR(a)), radioactive ... forensic and serological specimens. , ,Promega ...
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
Medicine Products: